ABEO — ABEONA THERAPEUTICS INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 318306 ·
Last close
$6.42
Market Cap
$365.91M
52W High
$7.36
52W Low
$5.08
ADV30
1,384,313
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,720,000 | 6,024,000 | -23,033,000 | -17,075,000 | 198,494,000 | 61,374,000 | 53,555,000 |
| Dec 2025 | 5,420,000 | 2,583,000 | -22,911,000 | -20,460,000 | 219,570,000 | 78,437,000 | 60,354,000 |
| Sep 2025 | 0 | -488,000 | -24,018,000 | -5,161,000 | 231,095,000 | 82,884,000 | 59,862,000 |
| Jun 2025 | 400,000 | 300,000 | -22,792,000 | 108,833,000 | 246,233,000 | 163,535,000 | 82,657,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-77,728,000
Investing CF
$105,778,000
Financing CF
$17,050,000
CapEx
$-7,509,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.07
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-759,150,000
Inventory
$6,054,000
Receivables
$6,709,000
ST Investments
$106,897,000
EBIT TTM
$69,811,000
Pretax Income TTM
$66,239,000
Interest Exp TTM
$3,572,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,540,000
EBITDA
$-90,049,000
Free Cash Flow
$-56,589,752
Enterprise Value
$220,810,832
Total Cash
$168,271,008
Total Debt
$23,173,000
Shares Out
56,995,144
Trailing EPS
$0.95
Book Value
$2.55
ROE
71.0%
ROA
-38.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,820,000 | -89,448,000 | 71,183,000 | 219,570,000 | 60,354,000 | — | -76,326,000 |
| Dec 2024 | 0 | -64,211,000 | -63,734,000 | 108,931,000 | 64,900,000 | — | -56,015,000 |
| Dec 2023 | 3,500,000 | -48,200,000 | -54,188,000 | 64,002,000 | 49,176,000 | — | -37,009,000 |
| Dec 2022 | 1,414,000 | -45,257,000 | -39,696,000 | 64,214,000 | 37,453,000 | — | -43,483,000 |
TTM Snapshot
Revenues TTM
$2,309,000
NetIncome TTM
$-15,533,000
OpCashFlow TTM
$0
Assets (Latest)
$16,582,000
Forward EPS
$0.29
Max Pain — expiry 2026-09-18
max pain strike: $5.00 · spot: $6.42 · call oi: 4,222 · put oi: 1,131
Expected Move to 2026-09-18:
±$2.50
(38.94%) —
implied range
$3.92 –
$8.92
· ATM straddle on $6.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | $366.39M | $12.60 | — |
| TENX | TENAX THERAPEUTICS, INC. | $363.39M | $13.70 | — |
| EBS | Emergent BioSolutions Inc. | $372.53M | $7.22 | — |
| AVIR | Atea Pharmaceuticals, Inc. | $376.13M | $4.70 | — |
| NATR | NATURES SUNSHINE PRODUCTS INC | $354.34M | $20.15 | — |
News headlines (Yahoo Finance, 1h cache)
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
2026-07-21 11:30 · Yahoo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-01 11:30 · Yahoo
Insider Favorites: Top Growth Companies For June 2026
2026-06-10 17:35 · Yahoo
Top Growth Companies With Insider Ownership In June 2026
2026-06-10 11:35 · Yahoo
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth
2026-06-08 17:36 · Yahoo
Insider Favorites High Growth Companies June 2026
2026-06-08 11:35 · Yahoo
June 2026's Leading Growth Stocks With Insider Influence
2026-06-01 17:36 · Yahoo
3 Growth Stocks Insiders Are Betting On
2026-06-01 11:36 · Yahoo
3 Growth Stocks With Strong Insider Confidence
2026-05-29 17:36 · Yahoo
High Insider Stakes In Leading Growth Companies May 2026
2026-05-29 11:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.